PDU: Catheter For Crossing Total Occlusions
What it covers
To facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions (including subchronic and chronic total occlusions) in the peripheral vasculature prior to further percutaneous intervention, such as angioplasty, atherectomy or stent placement.
FDA’s definition of product code PDU, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262013 | Kiba CTO Crossing Catheter | Reflow Medical, Inc. | Aug 28, 2026 | Special |
| K252315 | Santreva-ATK Endovascular Revasculariztion Catheter | AngioSafe, Inc. | Sep 22, 2025 | Traditional |
| K251158 | PowerWire® 14 Radiofrequency Guidewire Kit | Baylis Medical Technologies, Inc. | Sep 11, 2025 | Traditional |
| K251376 | LimFlow ARC | LimFlow, Inc. | May 31, 2025 | Special |
| K232562 | PowerWire Radiofrequency Guidewire Kit | Baylis Medical Technologies, Inc. | Feb 28, 2024 | Traditional |
| K230159 | SoundBite® Crossing System XS Peripheral | Soundbite Medical Solutions, Inc. | Aug 28, 2023 | Traditional |
| K230594 | Tigereye ST CTO-Crossing Catheter | Avinger, Inc. | Apr 25, 2023 | Traditional |
| K221163 | Tunnel Crossing Catheter | Tractus Vascular, LLC | Jan 19, 2023 | Traditional |
| K221541 | LimFlow ARC | LimFlow, Inc. | Aug 31, 2022 | Traditional |
| K220544 | DABRA Excimer Laser System (DABRA Laser model RA-308 and DABRA Catheter model 2.0) | Ra Medical Systems,Inc | Jun 29, 2022 | Traditional |
Clearances by year
36 PDU 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 74 |
| 2025 | 3 | 59 |
| 2024 | 1 | 188 |
| 2023 | 3 | 221 |
| 2022 | 4 | 139 |
| 2021 | 3 | 144 |
| 2020 | 2 | 135 |
| 2019 | 1 | 48 |
| 2017 | 1 | 110 |
| 2016 | 2 | 60 |
| 2015 | 2 | 71 |
| 2014 | 3 | 97 |
| 2013 | 1 | 127 |
| 2012 | 6 | 68 |
| 2011 | 3 | 91 |
Who submits
20 applicants cleared a PDU device since 2011. 83% of the clearances went to applicants in United States, then Canada (14%) and Israel (3%). By type: Traditional 75% and Special 25%. 1 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Avinger, Inc. | 10 |
| Ra Medical Systems,Inc | 3 |
| Baylis Medical Technologies, Inc. | 2 |
| Boston Scientific Corp | 2 |
| C.R. Bard, Inc. | 2 |
| LimFlow, Inc. | 2 |
| Soundbite Medical Solutions, Inc. | 2 |
| AngioSafe, Inc. | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.1250.
Standards
21 CFR 870.1250 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent PDU clearances declared.
Ask about PDU
Questions about PDU
What is FDA product code PDU?
Product code PDU, “Catheter For Crossing Total Occlusions” in FDA's classification database, is a Class II device type under 21 CFR 870.1250 (percutaneous catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 58 clearances under PDU, 36 of them since 2011.
How many 510(k) clearances are there under PDU?
FDA’s 510(k) database listed 58 clearances under PDU as of Oct 29, 2026, 36 of them decided since 2011; the most recent decision was Aug 28, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a PDU 510(k)?
For the 4 PDU clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 67 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most PDU clearances?
Since 2011: Avinger, Inc. (10), Ra Medical Systems,Inc (3), Baylis Medical Technologies, Inc. (2), Boston Scientific Corp (2) and C.R. Bard, Inc. (2). 20 applicants have cleared a PDU device in that time.